Simoons, M.L.

patient study infarction trial heart treatment group therapy disease event mortality level death result artery effect angina outcome table syndrome artery disease analysis heparin placebo baseline value stroke troponin intervention elevation /iiia hospital circulation platelet heart failure perindopril investigator inhibitor abciximab thrombolytic therapy 30 days follow-up difference thrombolytic reduction receptor cardiol cardiology percutaneou blood survival ratio factor diabetes angioplasty failure surgery randomized model signi function reperfusion thrombolysi ck-mb infarct size revascularization glycoprotein month pressure population infarct eur heart j number troponin t change europa infusion european aspirin benefit